Form Bio Co. Ltd. (377220) — Financial Flexibility Index
Form Bio Co. Ltd. (377220) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of ₩-2.09 Billion (operating CF ₩-2.57 Billion minus capex ₩472.81 Million) represents 0% of total liabilities (₩38.97 Billion). Check Form Bio Co. Ltd. (377220) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Form Bio Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Form Bio Co. Ltd. across 6 annual periods. See 377220 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Form Bio Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Form Bio Co. Ltd.. For the full company profile including market capitalisation, see Form Bio Co. Ltd. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | ₩-13.81 Billion | ₩-14.70 Billion | ₩32.07 Billion | ▼ -130.3% |
| 2023 | -0.19x | ₩-4.15 Billion | ₩-20.85 Billion | ₩22.19 Billion | ▼ -108.3% |
| 2022 | 2.24x | ₩13.16 Billion | ₩-2.02 Billion | ₩5.87 Billion | ▲ +168.9% |
| 2021 | 0.83x | ₩10.00 Billion | ₩-1.17 Billion | ₩11.99 Billion | ▼ -19.9% |
| 2020 | 1.04x | ₩22.24 Billion | ₩15.61 Billion | ₩21.35 Billion | ▲ +350.6% |
| 2019 | 0.23x | ₩7.96 Billion | ₩5.68 Billion | ₩34.45 Billion | — |